Dr. Kim is chair of Solid Tumor Oncology and Investigational Therapeutics and is the Donald S. Kim Distinguished Chair for Cancer Research at the Levine Cancer Institute in Charlotte. He was previously associate professor and director of clinical research in the Department of Thoracic/Head and Neck Medical Oncology, Division of Cancer Medicine, at the University of Texas MD Anderson Cancer Center in Houston. 

He received his undergraduate and medical degrees from Northwestern University and completed a fellowship in medical oncology at MD Anderson Cancer Center. 

Dr. Kim studies novel targeted agents in the treatment and prevention settings and has expertise in lung, head and neck cancers. He chaired the Department of Defense Biomarker-based Approaches of Targeted Therapy for Lung Cancer Elimination (BATTLE) personalized medicine program in lung cancer. He is the author or coauthor of more than 100 published articles, book chapters, reviews in journals such as Lancet, Lancet Oncology, Journal of Clinical Oncology, Cancer Discovery, Clinical Cancer Research Cancer, and Cancer Prevention Research, involving cancer therapeutics and prevention with chemotherapy and novel targeted agents with particular emphasis on lung cancer and head and neck cancer.